{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:57:05Z","timestamp":1787021825374,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010770","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000}}],"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early detection of human yellow fever (YF) infection in YF-endemic regions is critical to timely outbreak mitigation. African National Laboratories chiefly rely on serological assays that require confirmation at Regional Reference Laboratories, thus delaying results, which themselves are not always definitive often due to antibody cross-reactivity. A positive molecular test result is confirmatory for YF; therefore, a standardized YF molecular assay would facilitate immediate confirmation at National Laboratories. The WHO-coordinated global Eliminate Yellow Fever Epidemics Laboratory Technical Working Group sought to independently evaluate the quality and performance of commercial YF molecular assays relevant to use in countries with endemic YF, in the absence of stringent premarket assessments. This report details a limited laboratory WHO-coordinated evaluation of the altona Diagnostics RealStar Yellow Fever Virus RT-PCR kit 1.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology and principal findings<\/jats:title>\n                    <jats:p>Specific objectives were to assess the assay\u2019s ability to detect YF virus strains in human serum from YF-endemic regions, determine the potential for interference and cross-reactions, verify the performance claims as stated by the manufacturer, and assess usability. RNA extracted from normal human serum spiked with YF virus showed the assay to be precise with minimal lot-to-lot variation. The 95% limit of detection calculated was approximately 1,245 RNA copies\/ml [95% confidence interval 497 to 1,640 copies\/ml]. Positive results were obtained with spatially and temporally diverse YF strains. The assay was specific for YF virus, was not subject to endogenous or exogenous interferents, and was clinically sensitive and specific. A review of operational characteristics revealed that a positivity cutoff was not defined in the instructions for use, but otherwise the assay was user-friendly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions and significance<\/jats:title>\n                    <jats:p>The RealStar Yellow Fever Virus RT-PCR kit 1.0 has performance characteristics consistent with the manufacturer\u2019s claims and is suitable for use in YF-endemic regions. Its use is expected to decrease YF outbreak detection times and be instrumental in saving lives.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0010770","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T13:45:08Z","timestamp":1662471908000},"page":"e0010770","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Laboratory evaluation of RealStar Yellow Fever Virus RT-PCR kit 1.0 for potential use in the global yellow fever laboratory network"],"prefix":"10.1371","volume":"16","author":[{"given":"Alison J.","family":"Basile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Niedrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Meurant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron C.","family":"Brault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin H.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Mossel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick N.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason O.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-8263","authenticated-orcid":true,"given":"Holly R.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"pntd.0010770.ref001","unstructured":"WHO. Yellow fever 2019 [updated 7 May 2019. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever."},{"key":"pntd.0010770.ref002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"TP Monath","year":"2015","journal-title":"J Clin Virol"},{"issue":"5","key":"pntd.0010770.ref003","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1371\/journal.ppat.0030075","article-title":"Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas","volume":"3","author":"JE Bryant","year":"2007","journal-title":"PLoS Pathog"},{"issue":"1","key":"pntd.0010770.ref004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2009.09.001","article-title":"Structure of yellow fever virus envelope protein domain III","volume":"394","author":"DE Volk","year":"2009","journal-title":"Virology"},{"issue":"9","key":"pntd.0010770.ref005","doi-asserted-by":"crossref","DOI":"10.3390\/ph14090891","article-title":"The Present and Future of Yellow Fever Vaccines","volume":"14","author":"CA Hansen","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"pntd.0010770.ref006","first-page":"1043","volume-title":"Fields Virology","author":"D MT Burke","year":"2001"},{"issue":"5","key":"pntd.0010770.ref007","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1710430","article-title":"Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak\u2014Final Report","volume":"381","author":"RM Casey","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"pntd.0010770.ref008","doi-asserted-by":"crossref","DOI":"10.3390\/v12111233","article-title":"Re-Emergence of Yellow Fever in Brazil during 2016\u20132019: Challenges, Lessons Learned, and Perspectives","volume":"12","author":"P de Oliveira Figueiredo","year":"2020","journal-title":"Viruses"},{"issue":"5","key":"pntd.0010770.ref009","doi-asserted-by":"crossref","first-page":"e1001638","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data","volume":"11","author":"T Garske","year":"2014","journal-title":"PLoS Med"},{"key":"pntd.0010770.ref010","unstructured":"WHO. Eliminate Yellow fever epidemics (EYE) strategy 2017\u20132026 2018 [updated 21 January 2018. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241513661."},{"issue":"14","key":"pntd.0010770.ref011","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":"Yellow Fever: A Decade of Reemergence","volume":"276","author":"SE Robertson","year":"1996","journal-title":"JAMA"},{"issue":"10","key":"pntd.0010770.ref012","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00827-18","article-title":"Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat","volume":"56","author":"JJ Waggoner","year":"2018","journal-title":"Journal of clinical microbiology"},{"key":"pntd.0010770.ref013","doi-asserted-by":"crossref","first-page":"402","DOI":"10.11604\/pamj.2021.38.402.28886","article-title":"Laboratory capacity assessments in 25 African countries at high risk of yellow fever, August-December 2018","volume":"38","author":"BW Johnson","year":"2021","journal-title":"Pan Afr Med J"},{"key":"pntd.0010770.ref014","author":"WHO","year":"2016"},{"key":"pntd.0010770.ref015","unstructured":"PAHO. Laboratory Diagnosis of Yellow Fever Virus infection\u20142018 2018 [Available from: https:\/\/www.paho.org\/en\/documents\/laboratory-diagnosis-yellow-fever-virus-infection-2018."},{"issue":"5","key":"pntd.0010770.ref016","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.38.5.1823-1826.2000","article-title":"Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections","volume":"38","author":"DA Martin","year":"2000","journal-title":"Journal of clinical microbiology"},{"issue":"2","key":"pntd.0010770.ref017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/CVI.00078-07","article-title":"Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus","volume":"15","author":"M Niedrig","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"pntd.0010770.ref018","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/jcm.4.6.503-510.1976","article-title":"Serum dilution neutralization test for California group virus identification and serology","volume":"4","author":"H Lindsey","year":"1976","journal-title":"Journal of clinical microbiology"},{"issue":"5","key":"pntd.0010770.ref019","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance","volume":"81","author":"SJ Thomas","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"pntd.0010770.ref020","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1128\/JCM.01799-12","article-title":"Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories","volume":"50","author":"C Domingo","year":"2012","journal-title":"Journal of clinical microbiology"},{"key":"pntd.0010770.ref021","unstructured":"UNGM. First request for EOI for WHO Evaluation of Molecular Assays for Detection of Yellow Fever Virus 2020 [Available from: https:\/\/www.ungm.org\/Public\/Notice\/110964."},{"key":"pntd.0010770.ref022","unstructured":"FIND. Target product profiles for identification of yellow fever infection 2019 [Available from: https:\/\/www.finddx.org\/wp-content\/uploads\/2019\/07\/YellowFeverVirus-TPPs-2019-07-30.pdf."},{"key":"pntd.0010770.ref023","unstructured":"WHO. Product: RealStar Yellow Fever Virus RT PCR Kit 1.0 2021 [updated 3 May 2021. Meeting report]. Available from: https:\/\/www.who.int\/publications\/m\/item\/product-realstar-yellow-fever-virus-rt-pcr-kit-1.0."},{"key":"pntd.0010770.ref024","unstructured":"ISO. In vitro diagnostic test systems\u2014Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens\u2014Part 2: Laboratory quality practice guide. ISO\/FDIS 17822\u201322020. p. 1\u201339."},{"issue":"6","key":"pntd.0010770.ref025","first-page":"56","article-title":"Development of a Real-Time Reverse Transcription-PCR Assay for Global Differentiation of Yellow Fever Virus Vaccine-Related Adverse Events from Natural Infections","author":"HR Hughes","year":"2018","journal-title":"Journal of clinical microbiology"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010770","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T14:03:27Z","timestamp":1663337007000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010770"}},"subtitle":[],"editor":[{"given":"Remi N.","family":"Charrel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010770","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]}}}